Research Canada announces leadership award winners
December 3, 2014
TORONTO – Three advocates of health research and health innovation were presented with the inaugural Research Canada Leadership Award. Dr. Michael Julius (pictured), Vice President of Research at Sunnybrook Health Sciences Centre, Russell Williams, President and CEO of Canada’s Research Based Pharmaceutical Companies (Rx&D) and The Centre for Addictions Research of British Columbia received the Research Canada Leadership Award at a ceremony held in conjunction with the Prix Galien Canada 2014 Innovative Drug Product award at the Health Research Foundation Gala. Read More
ST. JOHN’S – Memorial University will receive $50 million over the next five years to support a healthcare initiative that will provide enhanced, personalized patient care through genomics and the use of analytics.
Less than 20 percent of applied medical research is translated into a possible device, medication or therapy. The launch of the new Translational and Personalized Medicine Initiative (TPMI) aims to change that by bringing bench research to the patient’s bedside.